
Bluebird bio is a biotechnology business based in the US. Bluebird bio shares (BLUE) are listed on the NASDAQ and all prices are listed in US Dollars. Bluebird bio employs 323 staff and has a trailing 12-month revenue of around $4 million.
How to buy Bluebird bio stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BLUE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
What's in this guide?
Bluebird bio stock price (NASDAQ: BLUE)
Use our graph to track the performance of BLUE stocks over time.Bluebird bio shares at a glance
Latest market close | $3.48 |
---|---|
52-week range | $2.78 - $8.58 |
50-day moving average | $3.93 |
200-day moving average | $5.90 |
Wall St. target price | $6.90 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.29 |
Buy Bluebird bio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Bluebird bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bluebird bio price performance over time
Historical closes compared with the close of $3.48 from 2023-05-25
1 week (2023-05-19) | -6.95% |
---|---|
1 month (2023-04-27) | -5.43% |
3 months (2023-02-27) | -33.46% |
6 months (2022-11-25) | -54.15% |
1 year (2022-05-23) | N/A |
---|---|
2 years (2021-05-27) | -89.03% |
3 years (2020-05-27) | 61.67 |
5 years (2018-05-25) | 188.15 |
Is Bluebird bio stock undervalued or overvalued?
Valuing Bluebird bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bluebird bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bluebird bio's PEG ratio
Bluebird bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bluebird bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bluebird bio financials
Revenue TTM | $4 million |
---|---|
Gross profit TTM | $-247,244,000 |
Return on assets TTM | -16.19% |
Return on equity TTM | -39.87% |
Profit margin | 0% |
Book value | $3.34 |
Market capitalisation | $402.2 million |
TTM: trailing 12 months
Bluebird bio share dividends
We're not expecting Bluebird bio to pay a dividend over the next 12 months.
Have Bluebird bio's shares ever split?
Bluebird bio's shares were split on a 1544:1000 basis on 5 November 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1544 shares. This wouldn't directly have changed the overall worth of your Bluebird bio shares – just the quantity. However, indirectly, the new 35.2% lower share price could have impacted the market appetite for Bluebird bio shares which in turn could have impacted Bluebird bio's share price.
Bluebird bio share price volatility
Over the last 12 months, Bluebird bio's shares have ranged in value from as little as $2.78 up to $8.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bluebird bio's is 0.9296. This would suggest that Bluebird bio's shares are less volatile than average (for this exchange).
Bluebird bio overview
bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc. , and changed its name to bluebird bio, Inc.
Bluebird bio in the news
Will bluebird bio (NASDAQ:BLUE) Spend Its Cash Wisely?
bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational Progress
bluebird bio Announces First Quarter 2023 Earnings Date and Upcoming Investor Events
Frequently asked questions
What percentage of Bluebird bio is owned by insiders or institutions?Currently 1.04% of Bluebird bio shares are held by insiders and 70.263% by institutions. How many people work for Bluebird bio?
Latest data suggests 323 work at Bluebird bio. When does the fiscal year end for Bluebird bio?
Bluebird bio's fiscal year ends in December. Where is Bluebird bio based?
Bluebird bio's address is: 60 Binney Street, Cambridge, MA, United States, 02142 What is Bluebird bio's ISIN number?
Bluebird bio's international securities identification number is: US09609G1004 What is Bluebird bio's CUSIP number?
Bluebird bio's Committee on Uniform Securities Identification Procedures number is: 09609G100
More guides on Finder
-
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
-
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
-
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
-
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
-
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
Best online brokers & platforms to buy gold stocks in May 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert